EZZ to Use Strong FY21 Results to Expand Growth In International Marketsby NewsPosted on November 15, 2021January 26, 2025Comments are Disabled
New EZZ genomic products attract strong Chinese interest at CIIE 2021by NewsPosted on November 11, 2021January 26, 2025Comments are Disabled
EZZ Life Science transforms from distributor to integrated producer of genomic health productsby NewsPosted on November 10, 2021January 26, 2025Comments are Disabled
Strong FY21 Results Underpin EZZ’s Foothold in Growing Life Sciences Sectorby NewsPosted on November 3, 2021January 26, 2025Comments are Disabled
EZZ Marks Transition to Genomic Health Following Exceptional FY21 Performanceby NewsPosted on October 29, 2021January 26, 2025Comments are Disabled
EZZ Delivers Strong FY21 Operational Performance, Declares Dividendby NewsPosted on October 29, 2021January 26, 2025Comments are Disabled
EZZ Life Science Holdings (ASX: EZZ) Posts Strong Financial Resultsby NewsPosted on August 24, 2021January 26, 2025Comments are Disabled
Ausbiz: EZZ Life Science debuts on the marketby NewsPosted on March 3, 2021January 26, 2025Comments are Disabled
EZZ Life Science Holdings Limited to list on the ASX today following oversubscribed A$6m IPOby NewsPosted on March 3, 2021January 26, 2025Comments are Disabled
